PECFENT, HAS RECEIVED A POSITIVE OPINION

摘要

PecFent is an aqueous fentanyl citrate solution using Archimedes Phama's proprietary PecSys~(TM) technology to allow fentanyl to be retained on the nasal mucosa and is designed to produce rapid but controlled absorption into systemic circulation. Archimedes Pharma has announced that its lead product, PecFent, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA).